Professional Documents
Culture Documents
Antidiabetic Phytochemicals: A
comprehensive Review on
Opportunities and Challenges in
Targeted Therapy for Herbal Drug
Development
August 2020
DOI:10.31838/ijpr/2020.SP1.242
Authors:
Pawan Prabhakar
Indian Institute of Technology Kharagpur
Mamoni Banerjee
Public Full-text 1
ISSN 0975-2366
DOI: https://doi.org/10.31838/ijpr/2020.SP1.242
Review Article
ABSTRACT
The traditional system of medicine has shown much better improvement, less side effect, and less expensive as
compared to modern synthetic drugs in the treatment of diabetes mellitus. Medicinal plants and
phytochemicals have much importance in the present scenario in developing countries where resources are
limited. The effectiveness and activity of a phytochemical depend upon its binding ability with the target
molecules. Identification of the target molecule, its mechanism, and interaction with the specific phytochemical
drug, can be proved to be an efficient therapeutic against diabetes. This review addressed different classes of
molecules and enzymes involved in the pathogenesis of diabetes mellitus, antidiabetic activities of different
classes of phytochemicals, its activity on antidiabetic drug targets, as well as possibilities of herbal drug
development for diabetes in context with targeted therapy.
Keywords: Diabetes, synthetic drugs, side effects, herbal drugs, Phytochemicals, target molecules
1673| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
1674| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
associated with diabetic retinopathy. An increase have been identified involving autoimmunity,
in blood sugar level causes blood flow change, genetic susceptibility, and environmental factors.
thickening of the basement membrane, change in Type I diabetes is genetically associated with
blood flow to the retina, and retinal vascular some variations of HLA (Human Leukocyte
permeability due to activation of protein kinase C Antigen) class II alleles such as HLA-DQA1, HLA-
enzyme. Advanced glycation Ends (AGEs) DRB1and HLA-DQB1. Such genes are involved in
produced due to activation of glycation that from the translation of proteins that distinguishes and
pericyte loss and microaneurysm causes damage identifies the body’s protein from pathogen or
to the retina (Duh et al., 2017). invader’s protein (virus and bacteria). Type 1
3.3 Neural Disorder (Diabetes Neuropathy) diabetes is an autoimmune disorder in which the
In this state of neural disorder, the blood bodies sometimes attack their organ and tissues.
capillaries supply blood to the nerves that are Hence, the immune system damages pancreatic
damaged. Diabetic neuropathy leads to complex β-cells for unknown reasons and secretion of
abnormalities such as polyneuropathy, thoraco- insulin is inhibited and symptoms of Type I
abdominal neuropathy, third nerve palsy, diabetic diabetes appears (Redondo et al., 2018).
amyotrophy, etc. Accumulation of polyols also
damages nerve fibers. In the state of Glutamic Acid Decarboxylase (GAD)
hypoglycemia, neuron mitochondrion produces Glutamic Acid Decarboxylase (GAD) is an enzyme
free radical species that damage DNA and other with a molecular weight of 65-67 KDa that works
cell membranes, inhibits the normal activity of cell as a catalyst in the conversion of glutamate to
and degeneration of nerve cells (Rolim et al., Gamma-Immunobutyric Acid (GABA) and carbon
2017). dioxide. Two isoforms of GAD are GAD65 (MW
65 KDa) and GAD67 (MW 67 KDa). It is a
Molecular Biology of Diabetes and
neurotransmitter, expressed in the insulin-
identification of therapeutic target molecules:
producing β-cells in the pancreas. GAD is the
By definition, a molecular entity or
chief candidate in auto-antigen involved in the
macromolecule whose property and function is
auto-immunity of β-cells (Ludvigsson, 2009) .
modulated by a particular drug or chemical
Menard et al (1999 ) reported that when non-
compound is known as ‘drug target’. In a
diseased condition, a drug target is crucial for obese diabetic (NOD) mouse was administered
with GAD inhibition in disease growth was
proper diagnosis and treatment. Finding a drug
observed.
target is the most important step in drug design
and discovery. An ideal drug target must have a DiaPep277
valid role in the pathophysiology of the disease, Diapep277 is a new molecular drug target that
must not express its distribution throughout the belongs to the class of heat-shock proteins made
body and must be responsive towards drug up of 24 amino acid peptides having a molecular
interaction(Schenone et al., 2013). If the target is weight of 60kDa. Heat shock proteins are the
known and valid, the process of drug family of proteins, produced by the cells, releases
development is highly facilitated by the rational during stress conditions, and other external stimuli
design of a new drug molecule with high efficacy such as wound healing, cold, tissue-regeneration,
and no adverse effect. In the case of diabetes UV light, etc (Morimoto, 1993). The human
mellitus, many drug targets have been identified variant of pep277 was administered in diabetic
but it is still a big challenge to treat diabetes with female mice inoculated with T-cells. When T-cells
high efficacy (Huggins et al., 2012). Researchers were vaccinated specifically for p277 peptide; it
have done a lot of work to improve the work of prevented pancreatic β-cells from destruction in
insulin on targeted sites and also tried to identify NOD diabetic mice for 7 months; reduction in
the lead to successfully improve the secretion of both anti-human hsp65 and antibodies was
insulin by pancreatic islet cells. Hence, in the last reported. In another experiment, the
20 years, researchers have concluded the administration of pep277 also prevented one-
following target molecules that can be modified month-old mice from hyperglycemia(Dana Elias
by natural and synthetic drugs in diabetes et al., 1991). When pep277 was administered to
mellitus(Sperling et al., 2003). the 12, 15, and 17 weeks old mice at a dose of
Therapeutic Targets for Type 1 Diabetes 50µg and after 40 days, only one of the mice was
Type 1 diabetes accounts for 5%-10% of the total died due to hyperglycemia, it was concluded that
diabetic population and can be characterized by p277 can arrest the autoimmune response (Elias
the high blood sugar level and no insulin & Cohen, 1994). In the human trial, it was
production by pancreatic β-cells. The actual cause demonstrated that diapep277 is effective in the
maintenance of c-peptide production for a short
of type I diabetes is known but certain risk factors
1675| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
duration and reduces the need for insulin but transduction and cellular responses. GPR120
there is a need for long term trial and follow-up belongs to rhodopsin G protein-coupled receptor
data. Daipep277 was also proved to be efficient groups that are preferably expressed in the
in curing patients with LADA as the destruction of intestinal epithelium and adipose
β-cells takes time as compared to type I diabetes. tissue(Trzaskowski et al., 201 2). Activation and
It can be highly susceptible to the intervention in secretion of glucagon are done by GPR120 which
the autoimmune process so, favors its efficacy in is responsible for the level of insulin secretion.
LADA patients(Raz et al., 2001). Hence, GPR120 is found to be a potential
The therapeutic target for Type 2 diabetes: therapeutic target for diabetes mellitus. Besides,
Type 2 diabetes is also referred to as Non-Insulin GPR120; GPR140, and GPR119 are also suitable
Dependent Diabetes Mellitus (NIDDM) because targets in developing drug molecules. GPR is
there is no need for insulin administration significant in stimulating insulin secretion together
externally as compared to Type 1 diabetes. As with suppressing the secretion of glucagon
reported earlier, 90%-95% of the patients are (Milligan et al., 2014; Fredriksson et al., 2003).
suffering from type 2 diabetes. Type 2 diabetes
Glucose Transporter Type 4 (GLUT 4)
can be treated by a change in diet, proper
Glucose Transporter 4 or GLUT 4 is a polypeptide
medication, and exercise (Li et al., 2010).
made up of 509 amino acids in the cell
However, despite high efficacy drugs diabetes is
membrane, has an efficient role in blood glucose
still a crucial challenge and researchers are
reduction. It has a crucial role in insulin resistivity
continuously working in search of a safer and
and regulates body glucose balance. It helps in
high potential natural and synthetic derivatives on
the movement of glucose into the cells with a
many target molecules with the strong evaluation
responding mechanism associated with insulin.
of the mechanism of drug action leads to
Gene alteration or mutation in this receptor
concrete validation of a target molecule
causes Type 2 diabetes. This can be a potential
(Prabhakar & Doble, 2008).
target for the development of antidiabetic
α-glucosidase Inhibitors drugs(Huang & Czech, 2007; Thunell et al.,
α-glucosidase is one of the main active enzymes 1988).
that have a vital role in carbohydrate absorption.
Nuclear Factor Kappa Light Chain Enhancer of
α-glucosidase inhibitors are the class of enzymes Activated B-cells (NFKB)
that slows or retard the rate of d-glucose as a Nuclear Factor Kappa Light Chain Enhancer of B
byproduct of the carbohydrates metabolism. This cells (NFKB) is a polypeptide complex that has a
inhibitory action results in a postprandial significant role in cytokine production, cell signal
reduction in blood glucose levels hence reduce as well as the transcription of DNA. It has been
the chances of hyperglycemia (Lebovitz, 1997; demonstrated that NKFB has a significant role in
Kumar et al., 2011). the conduction of immune response. When the
Peroxisome Proliferator-Activated Receptor- bovine cell line is studied, it was found that when
Gamma (PPARᵧ) the plasma glucose level is high, free radical
Peroxisome Proliferator-Activated Receptor- species activation is generated which activates
Gamma (PPARᵧ) is a nuclear receptor that is NFKB. Free Fatty Acid (FFA) and pro-
expressed in adipose and fat tissues. PPARᵧ is inflammatory cytokines are also responsible for
responsible for regulating glucose metabolism the activation of NFKB. Such pathways have an
and fatty acid storage. PPARᵧ activates the genes important role in oxidative stress (ROS) induced-
that are involved in adipogenesis and lipid insulin resistance. Such stress-induced pathways
metabolism by adipose tissues (Rieusset et al., are proved to be a potential molecular target for
1999). It has been reported that complex the researchers to develop drug molecules that
formation takes place when some ligand or can inhibit the function of NFKB pathways(Benzler
agonist are attached to PPAR ᵧ that activate it and et al., 2016; Oeckinghaus & Ghosh, 2009).
bind with another transcriptional factor. It again P38 Mitogen-Activated Protein Kinase
binds to DNA motif specifically in promotor part (P38MAPK)
of the targeted gene. A drug like glitazones P38 Mitogen-Activated Protein Kinase belongs to
activates PPARᵧ which in turn activates sensitivity Mitogen-Activated Protein Kinase enzyme families
of insulin (Balasubramanyam & Mohan, 2000). that are susceptible to adverse and stressful
G-Protein coupled Receptor (GPR) conditions such as UV-irradiation, heat shock,
G-Protein coupled receptor is transmembrane cytokines, and osmotic shock. They have a
receptors that identify or detect molecules at the significant role in programmed cell death and
surface of the cells. It helps in internal signal autophagy (Segalés et al., 2016). P38MAPK
1676| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
genes are activated during hyperglycemic intestinal epithelium as well as proximal renal
conditions. P38MAPK pathway is also responsible tubule (Chao, 2014). SGLT2 is mainly involved in
for several cellular mechanisms viz. cell growths, transporting 90% of glucose reabsorbed by the
apoptosis, immunity and inflammation, and other kidneys. Inhibition of SGLT2 leads to stopping the
pathways. It has been reported that activation of reabsorption of filtered glucose and thus
P38MAPK is predominant while treating insulin hyperglycemia is controlled. Glycosuria formed in
and hyperglycemia (Igarashi et al., 1999). this process coupled with SLGT2 reduction calorie
and weight. Hence, SLGT2 inhibitors can be an
Sodium-Glucose Transporter 2 (SGLT 2)
efficient drug molecule in the drug development
Sodium-Glucose Transporter is the class of
process against diabetes mellitus(Gerich and
membrane proteins that are involved in the
Bastien, 2011).
transport of many macromolecules such as amino
acids, glucose, vitamins, ions in the membrane of
Fig.1: Pathways by which commonly prescribed oral hypoglycemic agents achieve glucose
homeostasis.
("Reprinted with permission from (G R Kokil et al, inhibition of phosphorylation leads to insulin
2015, Chem Rev, 10;115 (11):4719-43.doi: resistance (Hassanin et al., 2018).
10.1021/cr5002832. Copyright©2015.
Dipeptidyl Peptidase-4 (DPP4)
American Chemical Society”)
Dipeptidyl Peptidase-4 is a protein associated with
Stress Activated Protein Kinase/c-Jun NH (2) signal transduction, apoptosis, and immune
terminal Kinase (SAPK/JNK) regulation. It involves in glucose metabolism and
Stress Activated Protein Kinase/ c-Jun NH (2) degradation of GLP-1 like incretins. GLP-1 are
terminal Kinase (SAPK/JNK) plays an essential the peptide-1 glucagon when combined with
role in the development of organs. They belong to glucose-dependent insulinotropic peptide, they
the class of Mitogen-Activated Protein Kinase and stimulate the secretion of insulin and decrease the
susceptible to heat shock, UV, cytokines, osmotic secretion of insulin and decrease the secretion of
shock. They are activated by hyperglycemia, free glucagon. Hence DPP-4 inhibitors are the class of
radical species, oxidative stress, cytokines, and drugs that can inhibit the function of incretin
most crucially apoptosis. SAPK-JNK pathway (Deacon et al., 2004; Mentlein, 1999).
performs a significant pathway and direct
1677| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
Fig.2: Inhibition of Dipeptidyl Peptidase-4 (DPP4) results in the secretion of insulin together with
a decrease in glucagon level.
11β Hydroxysteroid Dehydrogenase (11β-HSD) 17β-Hydroxysteroid dehydrogenase Type 1
11β Hydroxy-Steroid Dehydrogenase (11β-HSD) It belongs to the group of alcohol oxidoreductase
is an enzyme of oxidoreductase class, responsible enzyme that has a vital function in the synthesis of
for the conversion of cortisone to cortisol. It is an estrogen estradiol. It is a potential biomarker for
NADP/NADPH dependent enzyme and hence a the identification of breast cancer and diabetes. It
much important role in liver, CNS, and adipose has been reported that increase insulin resistivity.
tissue metabolism. The conversion of cortisone to Hence, it is one of the preferred molecular targets
cortisol leads to increase blood sugar levels and for drug discovery (Nguyen & Le, 2012; Strong &
hyperglycemia. Hence, 11β Hydroxy-Steroid Study, 2002).
Dehydrogenase inhibitor can be a potential target
Solute Carrier Family 16 Member 11
in drug development for diabetes mellitus (Davani
(SLC16A11)
et al., 2004; Walker, 1999).
Rusu et al., 2017 reported a new target molecule,
Glucose Fructose-6-Phosphatase Solute Carrier Family 16 Member 11 (SLC16A11)
Amidotransferase (GFAT) which is a monocarboxylate, proton couples
Glucose Fructose-6-Phosphatase transporter, and subsequent inhibition of SLCA11
Amidotransferase (GFAT) is responsible for changes lipid and the fatty acid metabolic
controlling the glucose flux into the hexosamine mechanism that can increase the chances of Type
pathway. Synthesis of glucosamine from HBP 2 diabetes.
(Hexosamine Biosynthetic Pathway) can lead to
the movement of glucose into the cell. GFAT Role of Phytochemicals in Diabetes
catalyzes the conversion of fructose-6-phosphate Drugs available for the treatment of diabetes
into glucosamine-6-phosphate and responsible mellitus comprise many drugs like biguanides,
for glucose-induced insulin resistance by the sulfonylureas, α-glucosidase inhibitors, and
action on the hexosamine biosynthetic pathway glinides, either used alone or in the composition
(HBP), it can be a novel drug target for diabetes to get a better result. Still the side effects of drugs
mellitus(Buse, 2006; Chou, 2004). are the major challenges associated with it
(Prabhakar & Banerjee, 2020). Drugs like
1678| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
1679| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
about 800 plants have been identified that may phenolic acids, flavonoids, stilbenes, and lignans.
cure diabetes(Singh, 2011). A recommendation All the polyphenols have shown an
made by the World Health Organization to antihyperglycemic effect (Pandey & Rizvi, 2009) .
evaluate the traditional plants for the treatment of
Phenolic Acids
diabetes considering their efficacy, non-toxic
Phenolic acids are widely derived distributed
effect, less or no side effect (Modak et al., 2007).
polyphenols that are derived from the
While going through the enzymes and molecules
derivetization of benzoic acid with a peak
involved in the molecular mechanism of diabetes
absorbance at 280 nm C6-C1 derivative and C6-
mellitus, the majority of them are acting upon
C3 derivative cinnamic acid. Important phenolic
rapid absorption of carbohydrates that cause an
acids that are reported to be antioxidant and
increase in the level of blood glucose. Hence, one
antidiabetic include gallic acid, salicylic acid,
of the important therapeutic approaches is to
ferulic acid, caffeic acid, ellagic acid,
inhibit their carbohydrate absorption activity and
protocatechuic acid, p-coumaric acid, rosamic
keeping the postprandial plasma glucose level in
acid and elgol (Coryet et al., 2018). The
control.
antioxidant property of phenolic acid is due to the
The efficiency of phytochemicals extracted from
stabilization and delocalization of unpaired
several plants in reducing blood glucose levels
electrons of the phenolic ring (Verma & Srivastav,
has gained a scientific validation that highlights
2020). Jain et al (2010) reported that ethanolic
their role in curing diabetes. Further research is
extract of gallic acid extracted from Paspalum
essential in exploring their potential for new drug
scrobiculatum (Linn.) with a dose of 500mg/kg
formulation development and bioactive
when administered to alloxan-induced diabetic
compound from plants. It has been reported that
rats showed a decrease in plasma glucose level
the treatment of a patient having insulin-
from 181.67 ± 1.12 to 119.17±1.9 mg/dl on
dependent or non-insulin-dependent with herbal
15th day of administration. Ramesh et al, 2011
formulations has shown an effective remedy but
reported a significant reduction in the serum
many herbal formulations used today have not
glucose, triglyceride, total cholesterol, L DL-
gone under precise evaluation and cytotoxicities
cholesterol, VLDL cholesterol levels at a dose of
and their drug-to-drug interaction not have been
50mg/kg, and 100mg/kg (Patel & Goyal, 2011).
assessed. In the past few years, many
Ramkumar et al (2014) reported that
phytochemicals have been extracted, purified,
administration of gallic acid to alloxan-induced
and isolated from plants that have a remarkable
diabetic rats reduced the blood glucose level to
effect against diabetes. Some of the important
150 mg/dl at a dose of 20mg/kg. There was also
phytochemical compounds such as polyphenols,
a significant improvement in hemolysis in gallic
alkaloids, glycosides, amino acids, terpenoids,
acid administered mouse compared to
peptidoglycans, glycolipids, saponins and other
glibenclamide one and a reduction in lipid
compounds obtained from many plant sources
peroxidation. Gallic acid is also reported to be
that are reported and discussed as a potential
synergistically important in drug-herb interactions
agent for antidiabetic effect. Such phytochemicals
leads to ti improved therapeutic effect together
can improve metabolic disorders by regulating
with reduced side effects. (Oboh et al., 2016)
them and can delay complications related to
reported that acarbose, an antidiabetic drug
diabetes (Choudhury et al., 2018). Here, recent
together with gallic acid (75:25) have shown a
research reports and discussions on various
mild inhibitory effect on α-amylase and a high
classes of phytochemicals that are playing a
inhibitory effect on α-glucosidase as excessive
crucial role in the treatment of diabetes mellitus
inhibition of α-amylase could result in abnormal
are given below:
bacterial fermentation. Rena et al, 2015 reported
Polyphenols the antihyperglycemic activities of salicylic acid
Polyphenols are the secondary metabolites and anti-inflammatory effect by directly linked to
obtained from plants, primarily involved in NF-κB signaling. A recent report suggests direct
protection against UV-rays and aggression by activation of AMPK contributes to
pathogens (Aryaeian et al., 2017). Poly phenols antihyperglycemic activities of salicylic acids with
are proved to be protective against many diseases proper drug action-mechanism(Rena &
such as diabetes, cancer, osteoporosis, Sakamoto, 2014). The synergistic effect of
cardiovascular diseases, and neurodegenerative salicylic acid was observed when Figueroa-Pérez
disorders. Polyphenols are categorized based on et al ( 2015) reported the enhancement of
the number of phenol rings and structural antidiabetic property of Mentha piperba was
elements that bind these rings to each other. done using 2mM of salicylic acids leads to
Polyphenols are divided into four classes: decrease in glucose level up to 25%. Furthermore,
1680| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
1681| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
have shown high IC50 value of 21.75±8.81 and lower hepatic gluconeogenesis in diabetic rats
22.33±1.52 µg/ml followed by hypolaetin and (Jayaraman et al., 2018). Gao et al (2007)
kaempferol at 34.89±7.44 and 45. 93±8.6 reported chebulin, chebulinic acid, and
µg/ml whereas wogonin, techtochysirin, 8-hyrdo- chebulagic acid were isolated from the Terminalia
7-methoxyflavone, norwogenin and acetate chebula using 70% methanol as solvent and
showed the least activity which was less shown inhibiting activity against α-glucosidase. It
than100µg/ml. Li et al (2015) reported grape has been reported that these three compounds
seed having proanthocyanindin flavonoids have showed intestinal maltase inhibitory activity with
significant role in reducing reducing FBG, HbA1C IC50 of 670µm, 30µm, 97µm respectively. While
serum insulin, and systolic blood pressure. Such two phenolics compound, 3-O-galloylepicatechin,
flavonoids are also helpful in improving kidney and 3-O-galloycatechin was isolated from the
functions. Falvonoids like Galbridin, luteolin, Bergenia ciliate using 50% aqueous methanol
eurycarpin A, licochalconetin, glabrone, 4’-7 and demonstrated significant inhibitory action
Dihydroxyflavone, formonetin, glabrol, against α-glucosidase activity (Bhandari et al.,
licoflavone, A-C liquiritigenin and glabrol were 2008). Minaiyan et al (2014) reported that fruits
isolated from species Glycyrrhiza, family of Prunnus varicata contain phenolic compound
Fabacae. A significant activity was reported pruning that has the potential to inhibit the activity
against alpha-glycosidase (upto 95%) at a against α-glucosidase activity. Geetha et al
concentration of 5 µg/mL (Z. Guo et al., 2015). (1994) isolated a phenolic derivative
Granados et al (2015) reported that isolation of leucodelphinidin from the bark of Ficus
flavonoids such as 5,7,4’-trihydroxy-3-5’- benghalensis and a dose of 200 mg/kg was
Dimethoxyflavone from Jatropha gossypifolia highly effective on alloxan induced diabetic rats
from the family Euphorbiacae shown as and was found to be hypoglycemic. In other
significant increase in glucose uptaking in C2C12 experiment, Manickam et al (1997) reported that
myotubes. There was also a reduction in under marsupin and pterostilbene phenolic compound
the curve of glucose tolerance, which was found from heartwood; Pterocarpus marsupium
to be 32 percent. Chakravarthy et al (1981) significantly helpful in reducing the blood
reported an important flavonoid epicatechin pressure level of hyperglycemic rats. Yang et al (
isolated from the bark of Indian medicinal plant 2017) reported that total flavonoid extract of
Pterocarpus marsupium Roxb. A dose of 30mg/kg Oxytropis falcata Bunge results in lowering of
was significantly effective in protection against blood glucose level. (Hui et al., 2015) reported
alloxan induced diabetic albino rats. that the dried root of Radix puerariae contains
Another flavonoid epigallocatechin gallate isoflavone that has hypoglycemic effect and help
isolated from Camellia sinensis of family in lipid peroxide reduction. Huang et al (2018)
Theaceae has been significantly effective in reported antidiabetic activity of four flavonoids-
protecting β-cells from streptozotocin-induced apigenin, maackiain; leachianone A and
diabetic rats(Gomes et al., 1995). Mezei et al leachianone B isolated from Sophora davidi
(2003) reported that soy contains flavonoids like (French.) and invitro and invivo models suggested
High Isoflavone (HIS) that activates PPARᵧ that Sophora davidi (French.) promoted GLUT4
(Peroxisome Proliferator-Activated Receptor- expression and activated AMPK (Adenosine
gamma) that is responsible for transcription of Monophosphate-activated Protein Kinase)
many genes involved in lipid metabolism and phosphorylation in insulin target tissues of KKAy
insulin sensitization results in a significant mice, leads to ameliorate insulin resistance in
hypolipidemic and lowering blood glucose level. type 2 diabetes mellitus. Simultaneously,
In another research report, flavonoid, hesperetin activation of PPARᵞ and inhibiting activity of ACC
has shown lower glucose level and an (Acetyl-CoA carboxylase) was also observed.
improvement in glucokinase activity results in
Table 1: Antidiabetic flavonoids and their therapeutic effect
S.No Plant Name Phytochemicals Therapeutic Effects Part Used References
1. Ficus Kaempferol, Singnifying diabetic Stem bark (Keshari et al.,
racemosa quercetin, action, reduced 2016)
naringenin, blood glucose level,
baiclain restored body weight
2. Glycyrrhiza Glabrin Reduction in FBG root and (Wu et al., 2013)
glabra (Fast Blood Glucose) stolon
and MDA
(Melanodialdehyde),
1682| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
1683| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
stilbenes tetramers and trimers have highly and tannin are among alkaloids compounds
inhibiting properties against PTB1B with IC50 widely used by the people (Kim et al., 2011). A
values of 27.23 and 27.81 Μm respectively and number of alkaloids have been extracted that are
α-glucosidase with IC50 values of 13.57 and focused to show the significant hypoglycemic
14.39 μM respectively together with this two properties. Tiong et al ( 2013) reported that four
Trans-dimers were also reported to be DPPIV alkaloids- Four alkaloids-vindoline I, vindolidine
inhibiting activity (55.35% and 61.26%, 500 μM). II, vindolicine III and vindolinine IV were
Takizawa et al (2015) reported that resveratrol is extracted, isolated and purified from the leaves of
one of the highly investigated stilbenes that was Catharanthus roseus (L.) G.Don and MTT Assay
found too high potent in activating PPAR α due to for cytotoxicity evaluation, ORAC Assay for
the presence of 40-hydroxyl groups having a antioxidant activity, and DPPH Assay for cell
critical role in direct activation of PPARα. scavenging activity were performed and vindoline
I, vindolidine II, vindolicine III have no cytotoxic
Lignans activity towards pancreatic β-TC6 cells at a
Lignans are the polyphenols made up of C6-C3 concentration 25µg/ml. The compound
carbon units of n-propylbenzene skeleton. They vindolidine II, vindolicine III, and vindolinine IV
are cinnamic derived units. Entrolactone and have high inhibition activity towards protein
Entradiole Secoisolariciresinaol (SDG) tyrosine phosphatase-1B (PTP-1B) proved to them
Diglucosided Secoisolariciresinaol (SDG) are the to be antidiabetic compounds. In another
major lignans isolate from Linum usitatissimum experiment, Agrawal et al (2013) reported that
(flaxseed) was reported to show antioxidant and alkaloids isolated from the roots of Aerva lanata
active in controlling the generation of free Juss. and methanol extract was given at a dose of
radicals in diabetes mellitus (Maghsoudi, 2016). 10 and 20 mg/kg to streptozotocin-nicotinamide
Xu et al (2008) reported that the ethanol induced diabetic rats and a reduction in serum
extraction of total lignan from Fructus arctii which glucose level (>180±8mg/dl) was observed.
was given to alloxan-induced diabetic mice and Herbs like Berberis thunbergii, Berberis vulgaris,
rats at a dose of 2.0, 1.0, 0.5 gm /kg body Berberis patiolari and Berberis aquafolium
weight and 1.38, 0.69, 0.35 gm/kg bodyweight contain important alkaloid berberine that has
for 10 days. There was a notable reduction in the potential antihyperglycemic activity because it
blood glucose level, cholesterol, total cholesterol, inhibits the activity of α-glucosidase leads to a
and triglycerides while using glibenclamide as decrease in transport of glucose through intestinal
standard drugs. While Xu et al ( 2014) reported epithelium (Pan et al., 2003). The wild variety of
total lignin extract from Fructus arctii which Tinospora cordifolia has been recognized as the
showed invitro α-glucosidase inhibitory activity potential source of berberine as reported by(Singh
and promotes better hypoglycemic activity than et al., 2003). There was a significant reduction in
the standard drug nateglinide, together with the the level of HbA1C, total cholesterol, and
release of Glucagon-Like Peptide (GLP-1) and triglyceride and increased the secretion of insulin
Glucose-dependent-Insulinotropic-Polypeptide in diabetic mice when they were treated with
(GIP) in the GK (Goto-Kakizaki) mice. The berberine at a dose of 150mg and 350 mg/kg
histopathological study of pancreatic islets cells for 12 weeks consecutively Dong et al ( 2016).
revealed that there were irregularities in structure Whereas in another experiment Lan et al, 2015
and volume and number reduction was observed reported that when a dose of 500mg was given
compared to normal GK (Goto-Kakizaki) mice post-meal for 12 weeks to patients suffering from
cells. Shrunken unusual cellular changes such as diabetes mellitus, there is a reduction in Fast
coarse chromatin, mild hyperchromasia, and Blood Glucose (FBG) level, HbA1C level and post
pyknosis were the characteristics of abnormal prandial blood glucose together with significant
islets cells. Later on, treatment with Nateglinide change in lipid profile (Lan et al., 2015; Dong et
with total lignans was able to regenerate the al., 2016). Down-regulating the function of
structure to the normal control cells. glucose-6-phosphate and phosphoenolpyruvate
Alkaloids carboxykinase was observed when treated with
Alkaloids are the lower molecular weight berberine in diabetic mice (Jiang et al., 2015).
nitrogenous compound derived from amino acids Berberine is considered to be a high potential
like tryptophan, lysine, tyrosine etc. They are a alkaloid drug having the capacity to treat cardiac
structurally diverse group of over 12, 000 cyclic dysfunction, nephropathy and endothelial
nitrogen-containing compounds which are found dysfunction complications observed in diabetic
in about 20% of plant species (Kennedy and mouse (Chang et al., 2016; Tao et al.,
Wightman, 2011) Alkaloids are very popular and 2017).Constantino et al, 2003, reported the
widely used in the daily life to stay alert; caffeine isolation of three alkaloids, 5-β-
1684| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
1685| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
1686| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
peroxidation in rat liver as well as the evaluation fibres by 7gm/day as reported by Botnia Dietary
of its inhibitory effect was done by haemoglobin- (Ylönen et al., 2003).
δ-gluconolactone(δ-glue) assay, N-acetyl-glycyl-
Polysaccharides
lysine methyl ester-ribose assay and bovine-serum
Polysaccharides are the complex macromolecules
albumin assay (BSA) glucose assay(Xi et al.,
and long polymer chain of monosaccharides that
2010). Terpenes like astragalosides isolated from
are linked by glycosidic bonds. Plant cellulose,
Astragalus radix which can alter the bond
starch, glycogen are major classes of
formation between reducing sugars and amino
polysaccharides. They have the general formula
acids hence reducing Advanced Glycation End
Cx (H20)y composed of long-chain units of
Products (AGES) like carboxyl methyl lysine results
monosaccharides (CH2O)n , where n is the
in inhibiting protein-glycation process(Motomura
number of repeating units. Glucose, fructose,
et al., 2009). In another experiment Kuang et al
galactose, mannose, arabinose, rhamnose, and
(2011) reported that euscaphic acid and p-
xylose are important monosaccharides (Zong et
counaroylursolic acid were isolated from the root
al., 2012). Kumar Bhateja & Singh, (2014)
of Sanguisorba tenufolia family Rosaceace
reported an antidiabetic property of aqueous
showed inhibitory effect on α-glucosidase activity
extract of Acacia tortilis gum exudates.
with IC50 value of 0.67 and 0.62 Mm. Guo et al
Aconintans A, B, C, and D, the four glycans were
(2015) reported some new terpenoids like 3-O-
isolated from the roots of Aconitum carmichaeli,
olean-11,13 [18]-diene 23, 28-dioic acid was
family Ranunculacae showed an antihperglycemic
isolated from and Anoectochilus elwesii plant that
activity in alloxan-induced diabetic mice (Gray &
acts on insulin resistant human HepG2 cells leads
Flatt, 1997). Six glycan molecules named
to a reduction in glucose uptake activity
saccharans A, B, C, D, E, and F were extracted
Triterpenoids isolated from Agrimonia pilosa
from the stalk of Saccharum Officinarum, family
Ladeb showed a significant sensitization of insulin
Poaceae exhibited a prominent reduction in the
through activating PPAR ᵧ and downstream
blood glucose level in alloxan-induced
controlled genes. Curcuma longa, family
hyperglycemic mice(Hikino et al., 1985).
zinzberaccae was used to isolate a tricyclic
Polysaccharide isolated from corn silk was found
diterpenoids, tetraterpenoids from the leaves
to be hypoglycemic and hypolipidemic in
which showed antidiabetic activity and oxidative
streptozotocin-induced hyperglycemic mice. Such
stress(Motomura et al., 2009).
polysaccharides were also effective in reducing
Fibres blood glucose levels, total glycogen, and serum
Fibres are the complex food derived from plants total cholesterol in diabetic mice (Zhao et al.,
that cannot be broken into simpler parts by 2012).
digestive enzymes. Fibre improves intestinal
Glycosides
digestive efficiency, cholesterol reduction, and an
Glycosides are the macromolecules and acetal
increase in microbial mass. Chemically, dietary
derivatives forms when a monosaccharide reacts
fibre is a complex carbohydrate and lignin group
with alcohol. The bond results due to such linkage
of vegetable origin that supports laxation and
known as a glycosidic bond. Previous research
decrease fasting blood glucose level. The diet
work has been proven that glycosides have high
contains a high amount of mono, disaccharides,
potential in curing diabetes mellitus. Vennekens et
and fat increases higher chances of diabetes as
al, 2017 reported a new type of glycosides,
compared to diet having high fibre content
stevioside and rebandioside A which was isolated
(Gittelsohn et al., 1998). (Chau et al ( 2003)
from Stevia rebanundiana showed decrease in
reported that dietary fibre which is water-soluble
plasma glucose level in the hyperglycemic wild rat
as well as alcohol soluble obtained from the peel
by improvement in the secretion of glucose-
of Citrus sinesis, family Rutaceae showed a
induced insulin by TRPM5 (Transient Receptor
reduction in glucose diffusion and inhibition of α-
Potential cation channel subfamily M member 5)
amylase. McKeown et al (2002) reported that
channel(Philippaert et al., 2017). Liu & Li (2016)
intake of dietary fibre with daily diet maintains the
reported that new phenolic glycosides- 4-acyl-2,
BMI (Body Mass Index), total cholesterol, WHR
6-dimethoxyphenol glucoside (6), and
(Waist-to-Hip Ratio) and fasting insulin level. He
lipariglycoside K-O (1-5) was isolated from
also concluded that an increase in insulin
Liparis odorta was identified as an inhibitor of
sensitivity reduces the chances of diabetes. It may PTP1B (Protein Tyrosine Phosphatase 1B) and α-
due to the intake of whole-grain cereals and
glucosidase. Vitexin, 3-O-β-D rutinoside, and
dietary fibres. There is a reduction in fasting
isovitexin were glycosides isolated from the leaves
insulin level by 2.9 % by the intake of dietary
of Microcos pinaculata, family tilicae, and were
1687| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
observed to exhibit inhibitory activity against α- considered for testing phytochemical activities.
glucosidase (Chen et al., 2013). These enzymes are well known for their role in
Besides these organic compounds, inorganic increasing blood glucose levels and insulin
compounds have also a vital role in the treatment resistivity. There must be ongoing necessities to
of diabetes mellitus. Such inorganic compounds find more effective drugs that have multiple
are highly efficient in intervening in the targets with much fewer side effects as the single-
mechanism of diabetes mellitus and inhibiting the target drug has shown limited therapeutic effects.
enzymatic activity associated with it. High As phytochemicals have very much side effects
manganese content leaves of Medicago sativa, with the promise of better therapeutic activities
family Fabaceae was found to be highly effective there is a need for continuous focus on the
in IDDM (Insulin Dependent Diabetes Mellitus) determination of their activities and mechanism of
patients and it has also been reported that action on available multiple targets.
manganese is an important factor in
phosphorylation of insulin receptor (Luo et al., CONCLUSION
1998). Sulfur-containing the amino acid, S-allyl Medicinal plants and phytochemicals have much
cysteine sulphoxide, allicin obtained from Allium importance in the present scenario in developing
sativum is highly efficient in reducing blood countries where resources are limited. So far in
glucose level in diabetic mice (Yatsunami et al., this review, it has been demonstrated that
2003). phytochemicals are highly efficient in the
treatment of diabetes mellitus by acting on their
DISCUSSION specific targets. Regular uptake of herbal
Diabetes mellitus is recognized as the most medicines containing these phytochemicals can
common chronic metabolic disorder causes high be beneficial in reducing blood glucose levels and
morbidity and mortality. There is no such concrete other complications. Such complications are
and an efficient method is developed so far to promoted by the majority of enzymes and
cure it. Unhealthy lifestyle, unbalanced BMI (Body molecules. Hence, there is a need for some
Mass Index), less physical work, consumption of additional pathway or multi-targeted approach
high calorific value diet, smoking, alcoholism, that can be used to overcome the risk of renal,
some genetic and environmental factor are the eye, cardiovascular complexities. Phytochemicals
main causes of diabetes. From decades strategies have therapeutic potential to bind with the specific
are made to lower the glucose level and the drug target but their activities have been determined on
was designed to stimulate the secretion of insulin a limited number of enzymes and molecules.
as well as insulin controlled glucose uptake by the Identifying the potential multidrug target is crucial
tissues. But they are facing the problem of side to drug development and identification of
effects and serious complications. This review phytochemicals mechanism towards multi-target
reveals that several molecules are involved in the molecules can be a matter of huge research and
molecular mechanism of diabetes. Inhibition or provide a landmark in achieving efficient
affecting their activity may result in lowering therapeutic against diabetes without causing any
blood glucose levels or reduce the complexities side effects.
associated with diabetes. Synthetics drugs can
Conflict of research interests: The authors
reduce such complexities but they are facing the
declare no conflict of interest.
problems of lethal adverse effects. Hence, due to
side effects patients stops taking these medicines. Authors: All research done by the authors
Herbal drugs containing antidiabetic
Financial support: No
phytochemicals are much efficient in the
treatment of diabetes mellitus. It has been Conflict of interest: none
successfully demonstrated that synthetic drugs
when incorporated with herbal drugs have a REFERENCES
better therapeutic result with fewer side effects 1. ADA. (2003). Standards of Medical Care for
(also called synergism). Research reports have Patients. Diabetes Care, 25(1), 213–229.
suggested that phytochemicals are much capable 2. Adedara, I. A., Fasina, O. B., Ayeni, M. F., Ajayi,
of working on specific targets by inhibiting their O. M., & Farombi, E. O. (2019). Protocatechuic
activities, like α-amylase, α-glucosidase, and acid ameliorates neurobehavioral deficits via
Dipeptidyl Peptidase-4 (DPP4). Unfortunately, suppression of oxidative damage, inflammation,
most of the in-vitro and invivo studies have shown caspase-3 and acetylcholinesterase activities in
their activities on only a few enzymes and diabetic rats. Food and Chemical Toxicology,
molecules as the majority of target molecules are 125(December 2018), 170–181.
involved in diabetes mellitus and are still not https://doi.org/10.1016/j.fct.2018.12.040
1688| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
3. Agrawal, R., Sethiya, N. K., & Mishra, S. H. intolerance. Diabetes, 64(6), 1–38.
(2013). Antidiabetic activity of alkaloids of Aerva 14. Bhandari, M. R., Jong-Anurakkun, N., Hong, G.,
lanata roots on streptozotocin-nicotinamide & Kawabata, J. (2008). α-Glucosidase and α-
induced type-II diabetes in rats. Pharmaceutical amylase inhibitory activities of Nepalese
Biology, 51(5), 635–642. medicinal herb Pakhanbhed (Bergenia ciliata,
https://doi.org/10.3109/13880209.2012.761244 Haw.). Food Chemistry, 106(1), 247–252.
4. Ahmed, I., Adeghate, E., Sharma, A. K., Pallot, D. https://doi.org/10.1016/j.foodchem.2007.05.077
J., & Singh, J. (1998). Effects of Momordica 15. Bourebaba, L., Saci, S., Touguit, D., Gali, L.,
charantia fruit juice on islet morphology in the Terkmane, S., Oukil, N., & Bedjou, F. (2016).
pancreas of the streptozotocin-diabetic rat. Evaluation of antidiabetic effect of total
Diabetes Research and Clinical Practice, 40(3), calystegines extracted from Hyoscyamus albus.
145–151. https://doi.org/10.1016/S0168- Biomedicine and Pharmacotherapy, 82, 337–
8227(98)00022-9 344.
5. Alqahtani, A., Hamid, K., Kam, A., Wong, K. H., https://doi.org/10.1016/j.biopha.2016.05.011
Abdelhak, Z., Razmovski-Naumovski, V., … Li, 16. Buse, M. G. (2006). Hexosamines, insulin
G. Q. (2013). The Pentacyclic Triterpenoids in resistance, and the complications of diabetes:
Herbal Medicines and Their Pharmacological Current status. American Journal of Physiology -
Activities in Diabetes and Diabetic Endocrinology and Metabolism, 290(1), 1–8.
Complications. Current Medicinal Chemistry, https://doi.org/10.1152/ajpendo.00329.2005
20(7), 908–931. 17. Canivell, S., & Gomis, R. (2014). Diagnosis and
https://doi.org/10.2174/0929867311320070007 classification of autoimmune diabetes mellitus.
6. Altemimi, A., Lakhssassi, N., Baharlouei, A., Autoimmunity Reviews , 13(4–5), 403–407.
Watson, D., & Lightfoot, D. (2017). https://doi.org/10.1016/j.autrev.2014.01.020
Phytochemicals: Extraction, Isolation, and 18. Chang, W., Li, K., Guan, F., Yao, F., Yu, Y.,
Identification of Bioactive Compounds from Zhang, M., … Chen, L. (2016). Berberine
Plant Extracts. Plants, 6(4), 42. Pretreatment Confers Cardioprotection Against
https://doi.org/10.3390/plants6040042 Ischemia-Reperfusion Injury in a Rat Model of
7. Aryaeian, N., Sedehi, S. K., & Arablou, T. (2017). Type 2 Diabetes. Journal of Cardiovascular
Polyphenols and their effects on diabetes Pharmacology and Therapeutics, 21(5), 486–
management: A review. Medical Journal of the 494. https://doi.org/10.1177/1074248415627873
Islamic Republic of Iran, 31(1), 886–892. 19. Chao, E. C. (2014). SGLT-2 inhibitors: A new
https://doi.org/10.14196/mjiri.31.134 mechanism for glycemic control. Clinical
8. Asthana, R. K., & Sharrna, N. K. (1990). Diabetes, 32(1), 4–11.
Hypoglycemic Effect of Swerchirin from the https://doi.org/10.2337/diaclin.32.1.4
Hexane Fraction of Swertict chirayita. Planta 20. Chau, C. F., Huang, Y. L., & Lee, M. H. (2003). In
Medica, 57(2), 102–104. Vitro Hypoglycemic Effects of Different
9. Ayodele, O. E., & Alebiosu, C. O. (2004). Insoluble Fiber-Rich Fractions Prepared from
Diabetic Nephropathy A Review of the Natural the Peel of Citrus Sinensis L. cv. Liucheng.
History, Burden, Risk Factors and Treatment. Journal of Agricultural and Food Chemistry,
Journal of National Medical Association, 96(1), 51(22), 6623–6626.
1445–1454. Retrieved from https://doi.org/10.1021/jf034449y
papers2://publication/uuid/814519A7-2DBC- 21. Chaudhury, A., Duvoor, C., Reddy Dendi, V. S.,
4D9A-8B3C-8733C21B3054 Kraleti, S., Chada, A., Ravilla, R … M W
10. B. Gaikwad, S., Krishna Mohan, G., & Rani, M. S. C w o d d
(2014). Phytochemicals for Diabetes m o o d m
Management. Pharmaceutical Crops, 5(1), 11– m m o do oo
28. AN do o do
https://doi.org/10.2174/2210290601405010011 C Q B X X Y Y &
11. B.K.Chakravarthy, S. G. S. S. G. and K. D. G. A H A H o d
(1981). The prophylactic action of (−)- od od d oo o od
Epicatechin against alloxan induced diabetes in w o o om
rats. Life Sciences, 3(9), 675–687. d o o N P od
12. Balasubramanyam, M., & Mohan, V. (2000). do o
Current concepts of PPAR-γ signaling in C Y G P P Y R Z X Q
diabetes mellitus. Current Science , 79(10), W Y … Z Q W Α
1440–1446. G o d o d m o
13. Benzler, J., Ganjam, G. K., Pretz, D., Oelkrug, R., Q o o T M o o od
E., C., Koch, … Tups, A. (2016). Central G o d M o o m Mo
inhibition of IKKβ/NF-κB signalling attenuates
high fat diet-induced obesity and glucose do o mo
1689| International Journal of Pharmaceutical Research | Jan - Jun 2020 | Supplementary Issue 1
C o N H w K H Y Do Y C Y T Y Y X Z o X
d Ro d D O o A W & D To … C
M d B D D A Go M o om d o T D M
m o d o d d A D o B
o o o D R d Z D R U U
C P Hdm P o R
do o d do o
C o K C Mo D K & A W
o d o o P o om D o d d
R m m d m C
do o
C o d H P d M H C K M C do o
K Ko …K w P A R A H d A A P
A d o om o d m d o d M o T K D o
o d m A m w P m oo A o o M d P
o o T d o d Com m P B d d H M d d Vo
M d
do o m do o o
C owd G o D A K & P C D & Co R P d
d o m o d NOD m T
d d d d m o d
mm o d o o do o
P m oo B D R T B O V D Z
do o R W M D & Co R
Co H P o T m M & V o o mm mo d
M T Ro o Po o w T o o m D
H m H d ood m A M o o Po d o N o
R w o N o m A d m o o U d o
do o Am
Co o R mo d P o R do o
B T P o o P G … o P M G G o Co o M A
A d A o o d R mo Gom M & R ooC m o R
m oo o T om d o d o
od m o o m m o d
do o X o o ood d o
D B Po wood N B o G do o o
R m M K H d T O … K o o T P o A Z o P & o
A A d T M W H m d dO d
d G o o od d Ro D M R d
P βC D o D D C do D C
P m D
D d O K d d mm W m do o
H d P o m oo N G & W m N
P o d M o d d moo o d M d U d
m o H m B o Ad K dom
N do o m m d
do o d o R Hö d P Go m D
D o C A B & Ho öm M C & ö H B
o o d d d V A o o o o d m
o o o d m o odo G o o d o
d O o o o B
o D do o
do o G o H H Y N G o B P C
D m B M A & M d M & K w o o α
A d d o d m o o d Ad od N ood
m m o o d om M C m
o o o do o ood m
o P om d G o H H Y N X P Y &K w
do o m o o α o d
o T m R ood
P m R S m
C m X & W B P omo o
do o ood m o d om o d om A mo o
G ó P M D Mo P G d o d o d o
W o W M B A M o o PPAR o P m o o
D Zo o H & Bo M M
Q o d od o d om do o
o o G o Z N X X o T W &Z o
o o P m oo Y C m o d o o α
do o o d d o o o B
G B M w B C &A K T PTP B o od om o
H o m o od d G o o
d o d om o ood
d o o P oo d do o
P m oo H mm A R G Bo m
G dB D o m o T M G o & md A
od m o o o o Bo o m o
d o o m o w do d
T d m R w o o o o d o d
C P m oo R d d o P P oo
om
www m om o do o
= w o d& om= o & d= % H d K P o o G &
C d do o % C R D D o T oo
dd o o om d= o M d d A om P
MBA & = & d=do % NT RNAT ONA C NTR OR C NC
& =D o m +o + + od AND H GH T CHNO OGY T
Go H D M A M C H K M A M mo d M O H H
B R M G M H A M A d R A R H A N &R
… Y D D d A M B m o
o o D C o d d
do o d o o d Ro o APK NK
G o Wo T M H B w B om d d P m o
H G do R H A G &Z m B M
o ood o m o do o o
d o o d w d H o H Ko o C M Y &H T
d o N C d omm o o d o m o
o o N o od A d B o G od m
do o d m od P M d
G o D C o A &P o o G do o
D m o d H &C M P T G UT
do d W o o o d G o T o C M o m
M o m
do o do o m
Gom A V d omo R D M H Y H o T D W Y Z o P
m R M & G D K A C H & Y A d A
m o C m o o od R om o o
o o o m oo d d KK A M
do o A o o AMP A d Po K
Z
G do B N G A & do o
o o H D m W & T do B
o m o o od d R o o o m o
om o o o Mo d d o o M d C m
do o mo do o m
G B Y A M & P R N H Z G Z o X W R W Y B
ow m d & M d o o
Po d o N o o o o o o od R d
d o m m
G o T Z T Z o X X o B om d R d
P m R S m
m M H H Z K m & do o
G m d A P m o d K A K K m G K w P
m o oo d B dw M K m P R w A …
o d o M H K o d o o d om mo
m m B o d o m o d o d m
o m o d o d o o W
o d o o o o Mo o o o m oo
do o
do o m Km K M o K & Hw K
D o D d o P d od om P
o D d o o mV o d
R om d o www d o d d o dm o m
wo o m m o d AMP d o
m m Bo m d Bo R
m% A www d o o Comm o
wo o m m o do o
m m d K H X H W W Q H Y B
M W H T N Y W Z B & X Y G
H Z Y Y m T … K G T od om oo o o
G o o d o A Mo
m o d o d
w o o C o do o mo
K m B P & R
do o C A d o o o
w M M o o O A O C O & ddd o o
T m M A d d do o oo md o
d d d
d o o o G B oM d R o
o o o P m d P m oo do o
do o K m N w K m V &P O
α o d o om A
B G B R K m P A o o d
& K m V A d o P m o o R w
P m o m o do o
d d d Y C C C K T &
do o T α o d o
m R m A d om P o m
H & Ud M A m
o o od do o o m
m d o Z o Y Do Y Z Z W
o o o d d & G M o
d m o oo d d d o m
d B om d dP m o o d m m d
O o o o o o m oo
do o o
Do H B X Zo X do o
W K …Y P B o H A o d
o o KB AMPK o do oo d M o m
TORC w o oo C o No Am
d d d Wo d o o do o
G o oo M H X Y H C Y Y Y
do o w & Z X R dom d Do
o o A M &O M T B d d Do D mm A Co o d
o d d o C dM Do C d Com
d o M Tw R m
do o Mo A od T dA o
K A C o d B K &B d o d N d d w T D M
G Com o o d B d Com m dA
o m o om d m d M d
o d o o do o
o m oo Y B o Z Z D X D Y
P m R S m
Y & Y o d M o M m D H M G
o o d o A m m & H K C
d Mo M d R o A d A D Kd D
Mod o o A o H
do o mm D o oo d d D R
m G D m d R o
o d od Wo d o o C do o
C M K ow N M M B W o P
do o w W & P W o
Y Z C Z W R X X o o dw m o
C Y & X M U o o o d d do
o o od om m d m m O d
w o m Am o o C N o
R d om do o
oo om U B M R D d d V
CD o o o o
H & B A d d A d R o P d
mm o A o P o G o d do o
om odo M d C m M O B W R W P o M
do o R W T A & N o
o o d d o d m
Q C H G o Y & X o PPAR w o
m mo om o Z d m RAW
w d o o N o
Bo m Bo A G do o
R o M m M T Y d Ko H &M T
do o m D d om o P o oo d
d o T w GAD H R w
d D M o m R d do o
R w
do o dm M G U T M do H & H do
o o D M C o T No m B B D G o o d o o
K N Amo Ko D K R … R d N o d
G M C o o A B o o N o UPP
o o o od d o d do o
o o o o w M M G d A Mo d A
m D M d R m o P & O oo o
do o o d o P
do o C d o ood o d m
< ADDA > CO d o om d o oo d d
G d R P m
o C T C Q T
C … R G M Mod M D P o d G d &
M o o o od do d A w D m T P A R Ad
m o d om d H D R G d o
oo d o T om P A D m d H
o o P m oo d H D U d o T m o
do o D o o C Bo m d
M o d Z T o o d N o
o dm m o d m do o
d D O M D o Mo mo o R C
T o o o o
www o o m
d d d do o
M m M R m M ood Mo om K w Y K o N
om M A C o P N &R A B T m K T M No T …
A m o o d T A o d o d om
om P o m m o o N oo o d om o
P od o d d o d od o o
do o A d ood C m
P m R S m
do o M d C m
N N D T & T T d do o
o o d d Ad d
N N o d R m m K M V m R V P
N o oo N M C R P …
do o G P Po o
O o G O O B O d o M D d o o d d o d
& Ad A o d d o mo H m d
o α m d α o d o m To o o
o o o o o ood d do o
D A R d P G d P B H C N &
do o d N w om A G o
O A &G o T N B A dC Ro d
m o T o o d Co d M o D o D M
H o P Boo T
P G Y H Z W G w do o
P X D Z o X C …X Y Y R D A o A T m M M
T m o M & Co R β o w
om d o o o o o d d mm omod o
P M d w o o d D P
do o A dom d do d
P d K B & R P
o o d o d m do o
d d O d M d d R do do M A K & P A
C o G o d P d
do o o m D
P GBM GK m G PT do o d
A o o Po o R G & mo o K d
M d d V o C R o d od d w m o o m o
C o R R W o V R P d & d D oo o
Z d d Po o H m H do o
d D d
do o do o C R A d A o D Ro
X M V P Ro P … Vd H
P & Go R K o o
C do o o d o om o o d o
d d dm o d d o m d o D
P m o o R do o d
do o Ro m C d M K D R &
P K P o A M M o D A A m w o
W V m K …V m o d o
R o o d o m d o m d
o d o omo d o N oo UN
o o o TRPM N do o
Comm o R m M D o B & D o V
do o omm o d d m d
P P & B M d o o w
N o oo D D m m o d d d o
C d O o P m & d o o C Bo m
R do o B
P P & Do M AT R V Ho M d M G m M
B dT A o Tow d D o Go M o P … Co M
M U M d P C T D V D
D R w o o C A o Two D
do o M m C
P Y N K m K do o
C A G B D M M N A m d Q U M o Ad Z
… D B T A A M M P m V …
Po o T D d A o d d d
A o d Com o C To o o od A
P m R S m
o d d B oM d R do o o o
o T o K C & W o
do o o o o NR d HO
M B B A & N T do o d B om d
o o o R d
o w o o T R C o M &W m D
o
ood d A
do o o o
d m V m N R o N
& Y A m To H oo C Y H H A A
o o o C d P d M Wo W … Aw K
P d m o o oo A d d o d o o
d d d m N P od o d om C o G Do
R Mo
do o do o mo
o M D V W B K & T ow B D Y
C mo P A T d o d G o d d U D A &
m m o o m oo d A o o mo w GPCR
d d o N C m Boo o d m d C
do o m o M d C m
P d o & M o C o P R d om
R o o m m o www m o m d
A o o MAPK w % A www m d o
o C d D o m Boo d d=PMC
AUG T d d & M o do T o M
do o T o o d
P d C G o o K
V P o B & G o A C m oo K m o
C m d m d o o
T o o od o G d d o o do o dm
P m oo T d T U o Y Yo w T Ko o H &
o owo A O od d O d A & O w T M o o o
D C T o d o o m d o o o
m d o d A o Bo m P m oo
T d Com m A M d
do o
M A P o oo M & T o M Udd G R A A O m A M Co
G o T D T A M A G & K
D P m d o d o om
do o P m o
o T & d H T o
o U o o G o d do o o
d R o T D Am VM d H o H W Yoo W
d D C K A GAD mo o o od
w m B T o N P M M & d o o d m NOD
H d P M m m m m P mR
AR wo ood d M d U V m D K & P P Bo
ood d N o om o d o O R wo
do o d m d o m
T o d T K N o o M T d ood & T oo
O A C T o A K K N …
B Bo o m om do o T
P m m P o m W R C A d B R
G o o od d od
do o o m o mo w C
T w Y N R K
Y m H K od H & o H W T d o m d
T do o o o o M d o o
o m o o d o o M d P R
PPARα P o ON W K & Ho m G
P m R S m
mm o d d o o &O K αG o d o
C o A o om M V
do o ood d T oo R
W Z & H o m do o
o d o o o od Yö K o C Ko K C
om o m mod o d G oo Ao A & V M
m Mo M d R o A o o o d w o
m o m o d o
do o mm w d T Bo D d
X M H C T H W A C H D C
R … C M A o d d do o d
o o o od o Z C C G C A H X Y Z
om A d o d o X M &C A d
d m R do R o om P o d w PTP B α G o d
d DPP V o A R
do o X o o A d ood
C m
X Z W K G C & Y do o
o o o m o Z o W Y Y Y Z & C
o om A Com o o d o
o o d Go o K o d om o o om d
o o o m oo m o o o
do o Boo M omo
X Z W X Z o M M D Y do o om
Z H … d W T Z Y Z Q & H X A
A d A o To om om w o o m oo
A A o d d D o m oo d
M dR P o R o o N d
do o M d C m R
Y W Z W Q & do o
T To o od d om
O o B m o Z o Y &Z o W T o
R o R o o KK β A od w o o
N B mm o P w d B d do d o m
Com m dA M d d o
do o do o o
Y Q G m T Mod N P Zo A C o H & W
P o O D Z oo M …K B B A o d om
m o d o o A w o
o o o d C o d Po m
d N do o o
do o
Y m K o Y d O od
P m R S m